Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0F1AS
|
||||
| Former ID |
DNC011930
|
||||
| Drug Name |
1-METHYLXANTHINE
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [533429] | ||
| Formula |
C6H6N4O2
|
||||
| Canonical SMILES |
CN1C(=O)C2=C(NC1=O)N=CN2
|
||||
| InChI |
1S/C6H6N4O2/c1-10-5(11)3-4(8-2-7-3)9-6(10)12/h2H,1H3,(H,7,8)(H,9,12)/i1+1D3
|
||||
| InChIKey |
MVOYJPOZRLFTCP-KQORAOOSSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Adenosine A2a receptor | Target Info | Inhibitor | [533429] | |
| Adenosine A2b receptor | Target Info | Inhibitor | [533429] | ||
| Adenosine A1 receptor | Target Info | Inhibitor | [533429] | ||
| KEGG Pathway | Rap1 signaling pathway | ||||
| Calcium signaling pathway | |||||
| cAMP signaling pathway | |||||
| Neuroactive ligand-receptor interaction | |||||
| Vascular smooth muscle contraction | |||||
| Parkinson's disease | |||||
| Alcoholismhsa04015:Rap1 signaling pathway | |||||
| Alcoholismhsa04022:cGMP-PKG signaling pathway | |||||
| Sphingolipid signaling pathway | |||||
| Morphine addiction | |||||
| Pathway Interaction Database | HIF-2-alpha transcription factor networkcmyb_pathway:C-MYB transcription factor network | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.